BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17141971)

  • 1. Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis.
    Hirasawa N; Tsuji H; Ishikawa H; Koyama-Ito H; Kamada T; Mizoe JE; Ito Y; Naganawa S; Ohnishi Y; Tsujii H
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):538-43. PubMed ID: 17141971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma.
    Toyama S; Tsuji H; Mizoguchi N; Nomiya T; Kamada T; Tokumaru S; Mizota A; Ohnishi Y; Tsujii H;
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):270-6. PubMed ID: 23414768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II dose-escalation study.
    Tsuji H; Ishikawa H; Yanagi T; Hirasawa N; Kamada T; Mizoe JE; Kanai T; Tsujii H; Ohnishi Y;
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):857-62. PubMed ID: 17161555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
    Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?
    Cassoux N; Cayette S; Plancher C; Lumbroso-Le Rouic L; Levy-Gabriel C; Asselain B; Sastre X; Couturier J; Arrufat S; Piperno-Neumann S; Dendale R; Lehoang P; Desjardins L
    Retina; 2013; 33(7):1441-7. PubMed ID: 23514798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.
    Yanagi T; Mizoe JE; Hasegawa A; Takagi R; Bessho H; Onda T; Kamada T; Okamoto Y; Tsujii H
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):15-20. PubMed ID: 19046826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma.
    Daftari IK; Char DH; Verhey LJ; Castro JR; Petti PL; Meecham WJ; Kroll S; Blakely EA
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):997-1010. PubMed ID: 9392537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neovascular glaucoma after stereotactic radiotherapy for juxtapapillary choroidal melanoma: histopathologic and dosimetric findings.
    Fernandes BF; Weisbrod D; YĆ¼cel YH; Follwell M; Krema H; Heydarian M; Xu W; Payne D; McGowan H; Simpson ER; Laperriere N; Sahgal A
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):377-84. PubMed ID: 20864264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.
    Takihara Y; Inatani M; Fukushima M; Iwao K; Iwao M; Tanihara H
    Am J Ophthalmol; 2009 May; 147(5):912-8, 918.e1. PubMed ID: 19195639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007.
    Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):121-8. PubMed ID: 21945109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of androgen deprivation therapy on persistent genitourinary complications after carbon ion radiotherapy for prostate cancer.
    Ishikawa H; Tsuji H; Kamada T; Hirasawa N; Yanagi T; Mizoe JE; Akakura K; Suzuki H; Shimazaki J; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):78-84. PubMed ID: 18456419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of thymidine phosphorylase in choroidal malignant melanoma associated with neovascular glaucoma.
    Kase S; Saito W; Yoshida K; Namba K; Osaki M; Ohgami K; Shiratori K; Kitaichi N; Adachi H; Ito H; Ohno S
    Pathol Int; 2005 Sep; 55(9):569-73. PubMed ID: 16143032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of visual acuity in carbon ion radiotherapy: analysis of dose-volume histograms and prognostic factors.
    Hasegawa A; Mizoe JE; Mizota A; Tsujii H
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):396-401. PubMed ID: 16182466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neovascular glaucoma following proton-beam therapy. Case report].
    D'Hermies F; Meyer A; Morel X; Lumbroso L; Levy C; Desjardins L; Frau E; Halhal M; Elmaleh C; Berges O; Gauthier JB; Ferrand R; Delacroix S; Schlienger P; Schwarz L; Habrand JL; Mazeron A; Renard G
    J Fr Ophtalmol; 2001 Jan; 24(1):95-101. PubMed ID: 11240479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.
    Goto A; Inatani M; Inoue T; Awai-Kasaoka N; Takihara Y; Ito Y; Fukushima M; Tanihara H
    J Glaucoma; 2013 Sep; 22(7):572-6. PubMed ID: 22407392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.